Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivoStephan Fellner, Gert Fricker, Günther Bernhardt et al.|Journal of Clinical Investigation|2002Cited by 360
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivoStephan Fellner, Gert Fricker, Björn Bauer et al.|Journal of Clinical Investigation|2002Cited by 345
Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from the <i>p</i>-Glycoprotein (ABCB1) Modulator TariquidarMatthias Kühnle, Armin Buschauer, Michael E. Egger et al.|Journal of Medicinal Chemistry|2009Cited by 154
Guanidine−Acylguanidine Bioisosteric Approach in the Design of Radioligands: Synthesis of a Tritium-Labeled<i>N</i><sup>G</sup>-Propionylargininamide ([<sup>3</sup>H]-UR-MK114) as a Highly Potent and Selective Neuropeptide Y Y<sub>1</sub>Receptor AntagonistMax Keller, Armin Buschauer, Nathalie Pop et al.|Journal of Medicinal Chemistry|2008Cited by 48
Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligandsRalf Ziemek, Armin Buschauer, Albert Brennauer et al.|European Journal of Pharmacology|2006Cited by 42